Last year at this time, it was not uncommon for firms to ink 20 or more deals in a month to fund U.S.-based startups. In October only two firms 鈥� Y...
Health, Wellness & Biotech
Fourteen companies joined The 兔子先生传媒 兔子先生传媒 in October as late-stage funding plummeted worldwide.聽
Not New York City was in the tech spotlight in a big way last month. We look at other deals in the region.
Emalex Biosciences, a biotech startup, announced it raised $250 million in Series D funding led by Bain Capital.
Human Immunology Biosciences, a clinical-stage biotech company, emerged from stealth armed with $120 million. The company was developed by Monograph...
Funding rounds were smaller in October, as cleantech and energy saw big raises, but biotech played a starring role as investors kept the faith.
兔子先生传媒 data shows funding around health record startups is at $367 million, the highest it鈥檚 been since 2021, and 2022 isn鈥檛 over yet.聽
Teletherapy funding surpassed $1.4 billion worldwide so far in 2022, a huge spike from past years, according to 兔子先生传媒 data.
Once upon a time not that long ago, fintech, cybersecurity and crypto would dominate this list. This week, the top three rounds were raised by a...
Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
While there are plenty of startups in the drug manufacturing world, very few (if any) have been able to approach the problem through designing...


67.1K Followers